Articles From: Tilly's shares rise after earnings outlook lifted to Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Haplo-Identical Hematopoietic Stem Cell Transplant


Tilly's Inc. (TLYS) shares rose in the extended session Monday after the specialty retailer raised its fourth-quarter outlook.
Sign-up for Tilly's shares rise after earnings outlook lifted investment picks
SAN DIEGO and PHILADELPHIA, Jan.
Sign-up for Robbins Arroyo LLP: Five Below, Inc. (FIVE) Misled Shareholders According to a Recently Filed Class Action -- FIVE investment picks
Company Presenting at ICR XChange and Needham Conferences SAN DIEGO , Jan.
Sign-up for Turtle Beach Updates Full Year Sales Outlook investment picks
NEW YORK , Jan.
Sign-up for Harwood Feffer LLP Announces Investigation of RCS Capital Corporation investment picks
NEW YORK , Jan.
Sign-up for Harwood Feffer LLP Announces Investigation of NPS Pharmaceuticals, Inc. investment picks
BUFFALO, N.Y., Jan.
Sign-up for First Niagara Financial Group to Announce Fourth Quarter Results on January 23, 2015 investment picks
HCP (NYSE:HCP) announced the closing of a £220 million unsecured term loan.
Sign-up for HCP Completes £220 Million Unsecured Term Loan Fixed at 1.79% investment picks
ATHENS, Greece, Jan.
Sign-up for TOP Ships Announces Sale and Lease Back of Two Vessels investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G030278-001&sourceType=1 http://www.marketwire.com/library/MwGo/2015/1/13/11G030278/seaspan_logo-114676605876.jpg HONG KONG, CHINA--(Marketwired - January 13, 2015) - Seaspan Corporation (NYSE: SSW) announced today that the Company's Board of Directors has declared cash dividends on its common and preferred shares as follows: About Seaspan Seaspan provides many of the world's major shipping lines with creative outsourcing alternatives to vessel ownership by offering long-term leases on large, modern containerships combined with industry leading ship management services.
Sign-up for Seaspan Declares Quarterly Dividends on Common and Preferred Shares investment picks
MENLO PARK, Calif., Jan.
Sign-up for Intersect ENT Announces Preliminary 2014 Financial Results investment picks
OVERLAND PARK, Kan., Jan.
Sign-up for Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987097003&sourceType=1 http://www.ccnmatthews.com/logos/20091106-ccorp200.jpg TORONTO, ONTARIO --
Sign-up for Crocodile Gold Achieves Record Gold Production in 2014 With 222,312 Ounces Produced and Announces 2015 Production Guidance investment picks
SEI Investments Canada Company announces unitholders of Growth 70/30 Fund and Global Growth 100 Fund approve mandate changes Canada NewsWire TORONTO , Jan.
Sign-up for SEI Investments Canada Company announces unitholders of Growth 70/30 Fund and Global Growth 100 Fund approve mandate changes investment picks
http://media.marketwire.com/attachments/201411/81382_SmartracLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168679&ProfileId=051205&sourceType=1 RYE BROOK, NY --
Sign-up for AMAG, HP, Identiv, ImageWare Systems, SMARTRAC, StrikeForce, and Elite Interactive Discuss Security Solutions in SecuritySolutionsWatch.com Interviews investment picks
Canpotex Reaches Agreement with Sinofert Canada NewsWire SASKATOON , Jan.
Sign-up for Canpotex Reaches Agreement with Sinofert investment picks
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announced that newly published research has reaffirmed the ability of catheters protected with ARROWg + ard ® Technology to reduce both bloodstream infections and direct costs associated with treating those infections.
Sign-up for Teleflex Reports Study Results of ARROWg+ard® Technology Effectiveness in Preventing Infections and Associated Costs in an Infection-Prone Insertion Site investment picks
NETANYA, Israel , January 13, 2015 /PRNewswire/ -- Cellcom Israel Ltd.
Sign-up for Cellcom Israel Ltd. Announces 4G Frequencies Tender Results investment picks
(NRF Big Show 2015, Booth #3731) Verifone (NYSE: PAY) today announced that Delhaize America has selected Verifone’s multi-media, EMV and NFC-capable MX 925 payment terminals to enhance consumer engagement at the point of sale across all of Delhaize America’s U.S. locations.
Sign-up for Delhaize America Selects Verifone for Next Generation Consumer-Facing Payment Solutions investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G030282-001&sourceType=1 http://www.marketwire.com/library/MwGo/2015/1/13/11G030282/20080327-SEALOGO-724647055909.jpg HONG KONG, CHINA--(Marketwired - January 13, 2015) - Seaspan Corporation (NYSE: SSW) reports the MOL Express, a 4,600 TEU container vessel went aground in Tateyama Harbour, Japan on January 11, 2015.
Sign-up for Salvors Work to Free Grounded MOL Express investment picks
NEW YORK , Jan.
Sign-up for Harwood Feffer LLP Announces Investigation of Roka Bioscience, Inc. investment picks
HOUSTON , Jan.12, 2015 /PRNewswire/ -- Paragon Offshore plc ("Paragon") (NYSE: PGN) today announced that Julie A.
Sign-up for Paragon Offshore Names Julie A. Ferro As Vice President Human Resources investment picks
-Latest Patent Covers Methods to Identify Data Drops- PORTLAND, Ore.
Sign-up for Rentrak Granted Patent on TV Return Path Information investment picks
Accenture (NYSE:ACN) is once again positioned as a leader in datacenter transformation consulting and implementation, according to the recently published “IDC MarketScape: Worldwide Datacenter Transformation Consulting and Implementation Services 2014 Vendor Assessment.” 1 This IDC MarketScape report assessment is based on a comprehensive framework and set of parameters expected to be conducive to success in providing datacenter transformation consulting and implementation services.
Sign-up for Accenture Positioned as a Leader in IDC MarketScape: Worldwide Datacenter Transformation Consulting and Implementation Services for Second Consecutive Report investment picks
Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced that the first cohort of patients in the BP-004 trial has completed dosing with the Company’s genetically engineered donor T cells (BPX-501), after receiving a partial T depleted haplo-identical allogeneic hematopoietic stem cell transplant (haplo-HSCT). The trial in pediatric patients is evaluating whether BPX-501 T cells from partially mis-matched donors administered following HSCT are safe and can help speed immune reconstitution.
Sign-up for Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Haplo-Identical Hematopoietic Stem Cell Transplant investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Tilly's shares rise after earnings outlook lifted to Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Haplo-Identical Hematopoietic Stem Cell Transplant
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent